# Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3)

Study · id `cardio:ct-nct01120301` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01120301](<https://clinicaltrials.gov/study/NCT01120301>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01120301

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 1000 participants.

## Technical summary

Registry record NCT01120301. Randomized; quadruple masking; primary purpose treatment. Start 2010-09 (registry gives no type); primary completion 2012-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1000 participants (planned count; ClinicalTrials.gov record NCT01120301, source copy `cardio:ctgov-nct01120301-2013-11-15`, retrieved 2026-10-26)
- Start date: 2010-09 (registry gives no type) (ClinicalTrials.gov record NCT01120301, source copy `cardio:ctgov-nct01120301-2013-11-15`, retrieved 2026-10-26)
- Primary completion: 2012-09 (actual) (ClinicalTrials.gov record NCT01120301, source copy `cardio:ctgov-nct01120301-2013-11-15`, retrieved 2026-10-26)
- Completion: Not reported
- Countries: United States; Austria; Canada; Finland; France; Germany; Peru; Spain; Sweden; Switzerland (ClinicalTrials.gov record NCT01120301, source copy `cardio:ctgov-nct01120301-2013-11-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01120301-2013-11-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3)
- Acronym: NEST-3
- Condition: Acute Ischemic Stroke
- Intervention (Device): NeuroThera® Laser System
- Lead sponsor: PhotoThera, Inc
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Transcranial laser therapy in acute stroke treatment: results of neurothera effectiveness and safety trial 3, a phase III clinical end point device trial (`cardio:pubmed-25293665`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: fe408b61b8877c4ad249d9ce4df0c9ea97a46f1bf55ffd68cfd7dc17f92fb27e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
